Katrin Watschinger, PhD, Division of Biological Chemistry, Biocentre, Innsbruck Medical University
Publications
Striessnig J, Hoda JC, Koschak A, Zaghetto F, Müllner C, Sinnegger-Brauns MJ, Wild C, Watschinger K, Trockenbacher A, Pelster G. 2004. L-type Ca2+ channels in Ca2+ channelopathies. Biochem Biophys Res Commun 322(4):1341-6
Hendrich J, Van Minh AT, Heblich F, Nieto-Rostro M, Watschinger K, Striessnig J, Wratten J, Davies A, Dolphin AC. 2008. Pharmacological disruption of calcium channel trafficking by the alpha2delta ligand gabapentin. Proc Natl Acad Sci USA 105(9):3628-33
Mezghrani A, Monteil A, Watschinger K, Sinneger-Brauns M, Barrère C, Bourinet E, Nargeot J, Striessnig J, Lory P. 2008. A destructive interaction mechanism accounts for dominant-negative effects of misfolded mutants of voltage-gated Ca2+ channels. J Neuroscience 28(17):4501-11
Heblich F, Van Minh AT, Hendrich J, Watschinger K, Dolphin AC. 2008. Time course and specificity of the pharmacological disruption of the trafficking of voltage-gated calcium channels by gabapentin. Channels 2(1):4-9
Watschinger K, Horak SB, Schulze K, Obermair GJ, Wild C, Koschak A, Sinnegger-Brauns MJ, Tampé R and Striessnig J. 2008. Functional properties and modulation of extracellular epitope-tagged CaV2.1 voltage-gated calcium channels Channels 2(6):1-13
Watschinger K, Keller MA, Hermetter A, Golderer G, Werner-Felmayer G, Werner ER.2009. Glyceryl ether monooxygenase resembles aromatic amino acid hydroxylases in metal ion and tetrahydrobiopterin dependence. Biol Chem. 390:3-10